Wijburg, Martijn T <br/><br/>
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.  [electronic resource] 

 -  Journal of neurology, neurosurgery, and psychiatry  10 2016 
 - 1138-45 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-330X 
<br/><br/><label>Standard No.: </label>10.1136/jnnp-2016-313772  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Diagnosis, Differential<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Leukoencephalopathy, Progressive Multifocal--chemically induced<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--diagnostic imaging<br/>Natalizumab--adverse effects<br/>Pharmacovigilance<br/>Retrospective Studies